Study Exclusion reasons Rmk Reference
de Niet, 2017 case report or case series 'Two (4%) serious adverse events were reported in the peg­IFN plus adefovir group (admission to hospital for alcohol­ related pancreatitis [week 6; n=1] and pregnancy'
Roberts, 2010 case report or case series

Roberts Birth Defects Res. Part A Clin. Mol. Teratol. 2010; 88:551-9 10.1002/bdra.20682

Lu, 2015 not relevant exposure Chronic hepatitis B pregnant women were treated with Telbivudine during the third trimester of their pregnancy. After childbirth, the patients were either switched to CPIA treatment or stopped Telbivudine treatment...

Lu Liver Int. 2015; 35:1692-9 10.1111/liv.12753

Birgegard, 2018 Studies without separate analysis of the considered drug/class from other drugs/class Fifty-four pregnancies (40 patients) occurred. Nine patients had no therapy, 24 had IFN (one patient had HC IFN), 10 had anagrelide, eight had A-A, and three were receiving anticoagulant without CRT at the time that pregnancy was reported.

Birgegard Haematologica 2018; 103:51-60 10.3324/haematol.2017.174672